Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28408541 | 0.92 | — | — | |
| SCHEMBL6426799 | 0.88 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL36993 | 0.82 | CA1 (0.30) | — | |
| SCHEMBL27392869 | 0.81 | — | — | |
| SCHEMBL28414739 | 0.81 | — | — | |
| SCHEMBL7704485 | 0.74 | — | — | |
| SCHEMBL425715 | 0.74 | EPHX1 (0.35) | EPHX1 | |
| SCHEMBL28407153 | 0.74 | EPHX1 (0.35) | EPHX1 | |
| SCHEMBL6686768 | 0.73 | CA1 (0.30) | — | |
| SCHEMBL22126696 | 0.73 | CA1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3428175-B1 | METHOD FOR PRODUCING OLIGOSACCHARIDES AND POLYSACCHARIDES HAVING NON-PROTECTED SULFATE GROUPS | GLYTECH INC (JP) | 2024-09-25 | — | — | EP | claimed |
| CN-106715448-B | Process for preparing tris (trialkylsilyl) phosphine | SK化学公司 | 2020-03-03 | — | — | CN | claimed |
| EP-3222623-B1 | METHOD FOR PREPARING TRIS(TRIALKYLSILYL)PHOSPHINE | SK CHEMICALS CO LTD (KR) | 2019-08-28 | — | — | EP | claimed |
| WO-2026101726-A1 | HYDROCARBYL SILYL-SUBSTITUTED ANSA-METALLOCENES AND PROCESS FOR PREPARING LOW MELT ELASTICITY POLYOLEFINS | FORMOSA PLASTICS CORPORATON, U.S.A. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260131320-A1 | HYDROCARBYL SILYL-SUBSTITUTED ANSA-METALLOCENES AND PROCESS FOR PREPARING LOW MELT ELASTICITY POLYOLEFINS | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4741410-A1 | SOLUBILIZATION GROUP FOR POORLY WATER-SOLUBLE PROTEINS | Glytech, Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH INC (JP) | 2024-11-28 | — | — | US | disclosed |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | GLYTECH, INC. (JP) | 2024-10-01 | — | — | US | disclosed |
| EP-3428175-B1 | METHOD FOR PRODUCING OLIGOSACCHARIDES AND POLYSACCHARIDES HAVING NON-PROTECTED SULFATE GROUPS | GLYTECH INC (JP) | 2024-09-25 | — | — | EP | disclosed |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH, INC. (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-108884122-B | Method for producing sugar having sulfate group and/or phosphate group | 株式会社糖锁工学研究所 | 2022-06-07 | — | — | CN | disclosed |
| EP-2694491-A1 | BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | Amgen Inc. (US) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012138776-A1 | BENZODIOXEPINE AND BENZODIOXINE COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES | AMGEN INC. (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20070219161-A1 | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1740620-A1 | PREPARATION PROCESS OF OLIGOGLYCOSAMINOGLYCAN, AND REDUCING END GLUCURONIC ACID TYPE OLIGOCHONDROITIN SULFATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005092931-A1 | PREPARATION PROCESS OF OLIGOGLYCOSAMINOGLYCAN, AND REDUCING END GLUCURONIC ACID TYPE OLIGOCHONDROITIN SULFATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-10-06 | — | — | WO | disclosed |
| US-6723860-B2 | 7a-alkoxy-4H-pyrano[3,2-d]-oxazol-2(3H)-one and process for producing the same | UBE INDUSTRIES, LTD. (JP) | 2004-04-20 | — | — | US | disclosed |
| EP-1207162-B1 | 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same | UBE INDUSTRIES (JP) | 2004-02-25 | — | — | EP | disclosed |
| US-20020072612-A1 | 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same | UBE INDUSTRIES, LTD. (JP) | 2002-06-13 | — | — | US | disclosed |
| EP-1207162-A1 | 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same | Ube Industries, Ltd. (JP) | 2002-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020072612-A1 | 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same | ACSL1, ACSL4, ACSL3 | EPHX1 388/4885 |
| US-20070219161-A1 | Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same | OSTC, B3GAT3, CSGALNACT1 | EPHX1 3200/4885 |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | EPHX1 1958/4885 |
| US-20260131320-A1 | HYDROCARBYL SILYL-SUBSTITUTED ANSA-METALLOCENES AND PROCESS FOR PREPARING LOW MELT ELASTICITY POLYOLEFINS | SMC1A, HSPA4L, SMC4 | EPHX1 4599/4885 |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | QPCT, QPCTL, PTMS | EPHX1 1914/4885 |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | EPHX1 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.